Tag Archives: Raj Denhoy

Edwards Lifesciences (EW): New Buy Recommendation for This Healthcare Giant

In a report released today, Raj Denhoy from Jefferies maintained a Buy rating on Edwards Lifesciences (EW – Research Report), with a price target of $180. The company’s shares closed on Tuesday at $157.35. According to TipRanks.com, Denhoy is a

Analysts Are Bullish on These Healthcare Stocks: Wright Medical Group (WMGI), Voyager Therapeutics Inc (VYGR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Wright Medical Group (WMGI – Research Report) and Voyager Therapeutics Inc (VYGR – Research Report) with bullish sentiments. Wright Medical Group (WMGI)

Jefferies Keeps a Buy Rating on Abbott Labs (ABT)

Jefferies analyst Raj Denhoy reiterated a Buy rating on Abbott Labs (NYSE: ABT) on October 17 and set a price target of $80. The company’s shares closed on Friday at $67.59. According to TipRanks.com, Denhoy is a top 25 analyst

Wright Medical Group (WMGI) Receives a Buy from Jefferies

In a report released yesterday, Raj Denhoy from Jefferies reiterated a Buy rating on Wright Medical Group (NASDAQ: WMGI), with a price target of $30. The company’s shares closed yesterday at $26.30. According to TipRanks.com, Denhoy is a top 100

Insulet Corp (PODD) Receives a Rating Update from a Top Analyst

In a report released yesterday, Raj Denhoy from Jefferies reiterated a Buy rating on Insulet Corp (NASDAQ: PODD), with a price target of $97. The company’s shares closed yesterday at $85.89. According to TipRanks.com, Denhoy is a top 100 analyst

Hologic Receives a Rating Update from a Top Analyst

Jefferies analyst Raj Denhoy reiterated a Buy rating on Hologic (NASDAQ: HOLX) today and set a price target of $50. The company’s shares opened today at $43.46, close to its 52-week high of $45.09. According to TipRanks.com, Denhoy is a